LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 6 of total 6

Search options

  1. Article ; Online: Necrotizing soft tissue infection by Vibrio furnissii after a migratory journey by sea to the Canary Islands (Spain)

    Pedro Laynez-Roldán / María Pilar Gómez Álvarez / Onán Pérez Hernández / Diego García Martínez de Artola / Alex Almuedo-Riera / Natalia Rodríguez-Valero

    Travel Medicine and Infectious Disease, Vol 57, Iss , Pp 102678- (2024)

    2024  

    Keywords Vibrio furnissi ; Vibrio ; Marine bacteria ; Soft tissue infection ; Migrant ; Arctic medicine. Tropical medicine ; RC955-962 ; Infectious and parasitic diseases ; RC109-216
    Language English
    Publishing date 2024-01-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Article ; Online: Correction

    Daniel Camprubí / Alex Almuedo-Riera / Helena Martí-Soler / Alex Soriano / Juan Carlos Hurtado / Carme Subirà / Berta Grau-Pujol / Alejandro Krolewiecki / Jose Muñoz

    PLoS ONE, Vol 17, Iss

    Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients

    2022  Volume 5

    Keywords Medicine ; R ; Science ; Q
    Language English
    Publishing date 2022-01-01T00:00:00Z
    Publisher Public Library of Science (PLoS)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Book ; Online: Comparison of baseline characteristics, clinical presentation, treatment and outcomes of COVID-19 patients treated with and without ivermectin (IVM).

    Daniel Camprubí (4567339) / Alex Almuedo-Riera (9628959) / Helena Martí-Soler (8704029) / Alex Soriano (3091062) / Juan Carlos Hurtado (7354691) / Carme Subirà (9628962) / Berta Grau-Pujol (8125923) / Alejandro Krolewiecki (170639) / Jose Muñoz (3343469)

    2020  

    Abstract: Comparison of baseline characteristics, clinical presentation, treatment and outcomes of COVID-19 patients treated with and without ivermectin (IVM). ...

    Abstract Comparison of baseline characteristics, clinical presentation, treatment and outcomes of COVID-19 patients treated with and without ivermectin (IVM).
    Keywords Medicine ; Microbiology ; Cell Biology ; Molecular Biology ; Biotechnology ; Immunology ; Cancer ; Science Policy ; Infectious Diseases ; Virology ; ivermectin ; COVID -19 patients ; dose ; randomized trials ; efficacy ; COVID -19 patients Ivermectin ; SARS-CoV -2 in-vitro ; covid19
    Publishing date 2020-11-11T18:41:14Z
    Publishing country us
    Document type Book ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients.

    Daniel Camprubí / Alex Almuedo-Riera / Helena Martí-Soler / Alex Soriano / Juan Carlos Hurtado / Carme Subirà / Berta Grau-Pujol / Alejandro Krolewiecki / Jose Muñoz

    PLoS ONE, Vol 15, Iss 11, p e

    2020  Volume 0242184

    Abstract: Ivermectin has recently shown efficacy against SARS-CoV-2 in-vitro. We retrospectively reviewed severe COVID-19 patients receiving standard doses of ivermectin and we compared clinical and microbiological outcomes with a similar group of patients not ... ...

    Abstract Ivermectin has recently shown efficacy against SARS-CoV-2 in-vitro. We retrospectively reviewed severe COVID-19 patients receiving standard doses of ivermectin and we compared clinical and microbiological outcomes with a similar group of patients not receiving ivermectin. No differences were found between groups. We recommend the evaluation of high-doses of ivermectin in randomized trials against SARS-CoV-2.
    Keywords Medicine ; R ; Science ; Q
    Language English
    Publishing date 2020-01-01T00:00:00Z
    Publisher Public Library of Science (PLoS)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article ; Online: Trends in mortality of hospitalised COVID-19 patients

    Carolina Garcia-Vidal / Alberto Cózar-Llistó / Fernanda Meira / Gerard Dueñas / Pedro Puerta-Alcalde / Catia Cilloniz / Nicole Garcia-Pouton / Mariana Chumbita / Celia Cardozo / Marta Hernández / Verónica Rico / Marta Bodro / Laura Morata / Pedro Castro / Alex Almuedo-Riera / Felipe García / Josep Mensa / José Antonio Martínez / Gemma Sanjuan /
    Antoni Torres / JM Nicolás / Alex Soriano

    The Lancet Regional Health. Europe, Vol 3, Iss , Pp 100041- (2021)

    A single centre observational cohort study from Spain

    2021  

    Abstract: Background: We aimed to describe changes in characteristics and treatment strategies of hospitalised patients with COVID-19 and detail the mortality trend over time. Methods: Observational cohort study of all consecutive patients admitted ≥ 48 h to ... ...

    Abstract Background: We aimed to describe changes in characteristics and treatment strategies of hospitalised patients with COVID-19 and detail the mortality trend over time. Methods: Observational cohort study of all consecutive patients admitted ≥ 48 h to Hospital Clinic of Barcelona for COVID-19 (1 March–30 September 2020). Findings: A total of 1645 consecutive patients with COVID-19 were assessed over a 7-month period. Overall mortality (≤30 days) was 9.7% (159 patients), 7.7% in patients hospitalised in regular wards and 16.7 % in patients requiring ICU admission. Overall mortality decreased from 11.6% in the first month to 1.4% in the last month, reflecting a progressive, significant downward trend (p for trend <0.001). Patients’ age changed over time, peaking in June. Most changes in the use of antivirals and anti-inflammatory treatments were documented. Age (OR 1.1, CI 1.1–1.12), chronic heart disease, (OR 1.7, CI 1.1–2.9), D-dimer>700 ng/mL (OR 2.3, CI 1.3–4.1), ferritin>489 ng/mL (OR 1.9; CI 1.5–3.2), C-RP>7 mg/dL (OR 2.6; CI 1.5–4.6), and shorter duration from symptom onset to hospital admission (OR 1.11; CI 1.04–1.17) were factors associated with 30-day mortality at hospital admission. Conversely, hospital admission in the last months (OR 0.80; CI 0.65–0.98) was significantly associated with lower mortality. Interpretation: In-hospital mortality has decreased in patients with COVID-19 over the last, few months, even though main patient characteristics remain similar. Several changes made when managing patients may explain this decreasing trend. Our study provides current data on mortality of patients hospitalised with COVID-19 that might be useful in establishing quality of standard of care. Funding: EIT Health, European Union´s Horizon 2020 Research and Innovation Programme), EDRD. PPA [CM18/00132], NGP [FI19/00133], and CGV [FIS PI18/01061], have received grants from Ministerio de Sanidad y Consumo, ISCIII. Resumen: Contexto: Nuestro objetivo es describir los cambios en las características y las ...
    Keywords COVID-19 ; ICU admission ; Outcomes ; Mortality ; Public aspects of medicine ; RA1-1270
    Language English
    Publishing date 2021-04-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: Skin Manifestations in COVID-19

    Priscila Giavedoni / Sebastián Podlipnik / Juan M. Pericàs / Irene Fuertes de Vega / Adriana Herrera-García / Llúcia Alós / Cristina Carrera / Cristina Andreu-Febrer / Judit Sanz-Beltran / Constanza Riquelme-Mc Loughlin / Josep Riera-Monroig / Andrea Combalia / Xavier Bosch-Amate / Daniel Morgado-Carrasco / Ramon Pigem / Agustí Toll-Abelló / Ignasi Martí-Martí / Daniel Rizo-Potau / Laura Serra-García /
    Francesc Alamon-Reig / Pilar Iranzo / Alex Almuedo-Riera / Jose Muñoz / Susana Puig / José M. Mascaró

    Journal of Clinical Medicine, Vol 9, Iss 3261, p

    Prevalence and Relationship with Disease Severity

    2020  Volume 3261

    Abstract: Background: Data on the clinical patterns and histopathology of SARS-CoV-2 related skin lesions, as well as on their relationship with the severity of COVID-19 are limited. Methods and Materials: Retrospective analysis of a prospectively collected cohort ...

    Abstract Background: Data on the clinical patterns and histopathology of SARS-CoV-2 related skin lesions, as well as on their relationship with the severity of COVID-19 are limited. Methods and Materials: Retrospective analysis of a prospectively collected cohort of patients with SARS-CoV-2 infection in a teaching hospital in Barcelona, Spain, from 1 April to 1 May 2020. Clinical, microbiological and therapeutic characteristics, clinicopathological patterns of skin lesions, and direct immunofluorescence and immunohistochemical findings in skin biopsies were analyzed. Results: Fifty-eight out of the 2761 patients (2.1%) either consulting to the emergency room or admitted to the hospital for COVID-19 suspicion during the study period presented COVID-19 related skin lesions. Cutaneous lesions could be categorized into six patterns represented by the acronym “GROUCH”: Generalized maculo-papular (20.7%), Grover’s disease and other papulo-vesicular eruptions (13.8%), livedo Reticularis (6.9%), Other eruptions (22.4%), Urticarial (6.9%), and CHilblain-like (29.3%). Skin biopsies were performed in 72.4%, including direct immunofluorescence in 71.4% and immunohistochemistry in 28.6%. Patients with chilblain-like lesions exhibited a characteristic histology and were significantly younger and presented lower rates of systemic symptoms, radiological lung infiltrates and analytical abnormalities, and hospital and ICU admission compared to the rest of patients. Conclusion: Cutaneous lesions in patients with COVID-19 appear to be relatively rare and varied. Patients with chilblain-like lesions have a characteristic clinicopathological pattern and a less severe presentation of COVID-19.
    Keywords COVID-19 ; skin lesions ; chilblain ; histopathology ; coronavirus ; pandemic ; Medicine ; R ; covid19
    Subject code 610
    Language English
    Publishing date 2020-10-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top